STJ heads into earnings with value intact but Street more cautious

St. James's Place reports on 29 October with the stock trading at a meaningful discount to where analysts think it should be, and earnings-day history that is reliably uncomfortable.

The most striking tension in the data is between valuation and price trajectory. The consensus mean price target is £16.29, against a close of £10.77. That gap implies roughly 51% upside in the eyes of analysts who cover the stock, yet the share price has slipped 3.9% over the past month. EV/EBITDA has compressed by 0.41 turns over the same period, and the P/E multiple has narrowed by 0.43 to 10.5x. Factor scores reinforce the value case: earnings yield ranks in the 90th percentile of the ORTEX universe and EV/EBIT in the 94th. EPS momentum is also constructive, with 30-day and 90-day readings at 77 and 81 respectively. The one counterweight is a forward EPS growth score that ranks in just the 5th percentile, reflecting Street uncertainty about whether fee income can accelerate from here.

The lending market is not the story this week. Short interest remains negligible, and availability is vast, at 2,541% of short interest, meaning there are roughly 25 shares available for every one currently borrowed. Cost to borrow has edged up 17% on the week to 0.67%, but in absolute terms it remains firmly in low-cost territory, well within its recent range. The ORTEX short score ticked up to 45.8 from 41.8 a fortnight ago, a modest move that reflects slightly increased short-side interest but nothing close to a crowded trade. Positioning looks indifferent rather than confrontational.

The insider register is worth a brief note. Two open-market purchases were recorded in September: the Chair's closely associated person bought 3,624 shares at £10.98 on 23 September, and non-executive director Evelyn Bourke acquired 2,374 shares at £10.53 in July. Both are small in absolute terms, but they represent discretionary buying at prices below the current close. The CFO and COO both received share grants on 30 September, which are compensation mechanics rather than conviction signals, but they keep the register ticking over ahead of results.

Among closely correlated LSE peers, the week has been mixed to negative. ABDN fell 8.3% on the week, the sharpest move in the group, while LWDB dropped 5.2%. ASHM managed a 1% gain. STJ's 1.5% weekly rise looks relatively composed against that backdrop, though the one-month picture is softer for most names in the cohort.

The single earnings reaction in recent history shows a day-one fall of 2.3% on 29 July 2026, followed by a five-day recovery of 4.7%. That pattern, a sharp initial dip and subsequent drift higher, is the reference point going into next Wednesday's print. The gap between the consensus price target and the current share price means the key question for 29 October is less about whether STJ is cheap and more about what the company says regarding adviser flows, the pace of any regulatory remediation costs, and whether forward fee income guidance gives the Street a reason to close that valuation gap.